Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Decreased by Woodstock Corp

Woodstock Corp cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 87,007 shares of the medical equipment provider’s stock after selling 211 shares during the period. Intuitive Surgical accounts for 4.4% of Woodstock Corp’s investment portfolio, making the stock its 4th largest holding. Woodstock Corp’s holdings in Intuitive Surgical were worth $45,414,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. Massachusetts Financial Services Co. MA acquired a new stake in Intuitive Surgical during the third quarter worth approximately $558,807,000. International Assets Investment Management LLC lifted its position in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC boosted its stake in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB lifted its holdings in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, State Street Corp lifted its stake in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $584.08 on Friday. The firm has a market capitalization of $208.04 billion, a price-to-earnings ratio of 93.90, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $355.17 and a fifty-two week high of $585.50. The stock’s fifty day moving average is $538.34 and its two-hundred day moving average is $497.08.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 26.54 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock valued at $25,012,927 in the last ninety days. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on ISRG. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Royal Bank of Canada boosted their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Raymond James lifted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Truist Financial upped their price objective on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.